Swath Of Claims Cut From Wellbutrin Antitrust Action
A federal judge has dismissed most of the claims brought by a group of employee benefit plans in a putative antitrust class action alleging that Biovail Corp. and GlaxoSmithKline PLC conspired...To view the full article, register now.
Already a subscriber? Click here to view full article